Studies are therefore lacking that assess whether important adverse metabolic changes that may increase the risk of T2DM and obesity, such as impaired insulin sensitivity, are associated with changes in the gut microbiome and associated SCFAs that could result from recurrent sleep loss. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.